Its easy for Remdesivir to demonstrate a benefit of 5 days vs 10 days since it's causing organ failure the longer it's used. Too bad Leronlimab has a pristine safety profile?

Quote:

---

P.S. I’d like CYDY to pitch a change of primary endpoint to the FDA to 7 days and 14 days like Gilead but with hospitalizations and death rates included. This 6 week primary endpoint is garbage.

Read More: https://investorshangout.com/post/view?id=575...z6Lb3z5iAq

---